201 related articles for article (PubMed ID: 31532069)
1. Tau oligomers mediate aggregation of RNA-binding proteins Musashi1 and Musashi2 inducing Lamin alteration.
Montalbano M; McAllen S; Sengupta U; Puangmalai N; Bhatt N; Ellsworth A; Kayed R
Aging Cell; 2019 Dec; 18(6):e13035. PubMed ID: 31532069
[TBL] [Abstract][Full Text] [Related]
2. RNA-binding proteins Musashi and tau soluble aggregates initiate nuclear dysfunction.
Montalbano M; McAllen S; Puangmalai N; Sengupta U; Bhatt N; Johnson OD; Kharas MG; Kayed R
Nat Commun; 2020 Aug; 11(1):4305. PubMed ID: 32855391
[TBL] [Abstract][Full Text] [Related]
3. Formation of Toxic Oligomeric Assemblies of RNA-binding Protein: Musashi in Alzheimer's disease.
Sengupta U; Montalbano M; McAllen S; Minuesa G; Kharas M; Kayed R
Acta Neuropathol Commun; 2018 Oct; 6(1):113. PubMed ID: 30367664
[TBL] [Abstract][Full Text] [Related]
4. RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer's disease.
Bishof I; Dammer EB; Duong DM; Kundinger SR; Gearing M; Lah JJ; Levey AI; Seyfried NT
J Biol Chem; 2018 Jul; 293(28):11047-11066. PubMed ID: 29802200
[TBL] [Abstract][Full Text] [Related]
5. Lysine 63-linked ubiquitination of tau oligomers contributes to the pathogenesis of Alzheimer's disease.
Puangmalai N; Sengupta U; Bhatt N; Gaikwad S; Montalbano M; Bhuyan A; Garcia S; McAllen S; Sonawane M; Jerez C; Zhao Y; Kayed R
J Biol Chem; 2022 Apr; 298(4):101766. PubMed ID: 35202653
[TBL] [Abstract][Full Text] [Related]
6. Tau aggregates are RNA-protein assemblies that mislocalize multiple nuclear speckle components.
Lester E; Ooi FK; Bakkar N; Ayers J; Woerman AL; Wheeler J; Bowser R; Carlson GA; Prusiner SB; Parker R
Neuron; 2021 May; 109(10):1675-1691.e9. PubMed ID: 33848474
[TBL] [Abstract][Full Text] [Related]
7. Novel drugs affecting tau behavior in the treatment of Alzheimer's disease and tauopathies.
Navarrete LP; Pérez P; Morales I; Maccioni RB
Curr Alzheimer Res; 2011 Sep; 8(6):678-85. PubMed ID: 21605038
[TBL] [Abstract][Full Text] [Related]
8. RNA-binding MSI proteins and their related cancers: A medicinal chemistry perspective.
Liu C; Chen H; Cao S; Guo J; Liu Z; Long S
Bioorg Chem; 2024 Feb; 143():107044. PubMed ID: 38134522
[TBL] [Abstract][Full Text] [Related]
9. The role of tau oligomers in the onset of Alzheimer's disease neuropathology.
Cárdenas-Aguayo Mdel C; Gómez-Virgilio L; DeRosa S; Meraz-Ríos MA
ACS Chem Neurosci; 2014 Dec; 5(12):1178-91. PubMed ID: 25268947
[TBL] [Abstract][Full Text] [Related]
10. Neuron-selective toxicity of tau peptide in a cell culture model of neurodegenerative tauopathy: essential role for aggregation in neurotoxicity.
Zhao K; Ippolito G; Wang L; Price V; Kim MH; Cornwell G; Fulenchek S; Breen GA; Goux WJ; D'Mello SR
J Neurosci Res; 2010 Nov; 88(15):3399-413. PubMed ID: 20882568
[TBL] [Abstract][Full Text] [Related]
11. Perinuclear Lamin A and Nucleoplasmic Lamin B2 Characterize Two Types of Hippocampal Neurons through Alzheimer's Disease Progression.
Gil L; Niño SA; Chi-Ahumada E; Rodríguez-Leyva I; Guerrero C; Rebolledo AB; Arias JA; Jiménez-Capdeville ME
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32155994
[TBL] [Abstract][Full Text] [Related]
12. Pathological Tau Strains from Human Brains Recapitulate the Diversity of Tauopathies in Nontransgenic Mouse Brain.
Narasimhan S; Guo JL; Changolkar L; Stieber A; McBride JD; Silva LV; He Z; Zhang B; Gathagan RJ; Trojanowski JQ; Lee VMY
J Neurosci; 2017 Nov; 37(47):11406-11423. PubMed ID: 29054878
[TBL] [Abstract][Full Text] [Related]
13. Azure C Targets and Modulates Toxic Tau Oligomers.
Lo Cascio F; Kayed R
ACS Chem Neurosci; 2018 Jun; 9(6):1317-1326. PubMed ID: 29378132
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of tau self-aggregation and neurotoxicity.
Farías G; Cornejo A; Jiménez J; Guzmán L; Maccioni RB
Curr Alzheimer Res; 2011 Sep; 8(6):608-14. PubMed ID: 21605046
[TBL] [Abstract][Full Text] [Related]
15. Tau oligomers as potential targets for immunotherapy for Alzheimer's disease and tauopathies.
Lasagna-Reeves CA; Castillo-Carranza DL; Jackson GR; Kayed R
Curr Alzheimer Res; 2011 Sep; 8(6):659-65. PubMed ID: 21605039
[TBL] [Abstract][Full Text] [Related]
16. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
Stancu IC; Ferraiolo M; Terwel D; Dewachter I
Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of autophagy and stress granule-related proteins in stress-driven Tau pathology.
Silva JM; Rodrigues S; Sampaio-Marques B; Gomes P; Neves-Carvalho A; Dioli C; Soares-Cunha C; Mazuik BF; Takashima A; Ludovico P; Wolozin B; Sousa N; Sotiropoulos I
Cell Death Differ; 2019 Aug; 26(8):1411-1427. PubMed ID: 30442948
[TBL] [Abstract][Full Text] [Related]
18. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
[TBL] [Abstract][Full Text] [Related]
19. Tau Fibril Formation in Cultured Cells Compatible with a Mouse Model of Tauopathy.
Matsumoto G; Matsumoto K; Kimura T; Suhara T; Higuchi M; Sahara N; Mori N
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772786
[TBL] [Abstract][Full Text] [Related]
20. Zn
Li X; Du X; Ni J
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30678122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
